SSSI
Substitution arrangement for fluoxetine
Temporary approval granted for replacement oral fluoxetine product as shortage continues Due to the shortage of fluoxetine (brand name: Zactin Tablet), the Federal Department of Health has announced it has …
Fluoxetine update
The TGA has made a Serious Scarcity Substitution Instrument regarding fluoxetine 20mg dispersible tablets To help manage the shortage of the dispersible tablet form of this dose, the Therapeutic Goods …
PBS funding for vigabatrin substitution
PBS confirms subsidy arrangements for vigabatrin under a serious scarcity substitution instrument (SSSI) An amendment to the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination …
Ryzodeg product in shortage till mid-2024
A Serious Scarcity Substitution Instrument has been made for Ryzodeg 70/30 FlexTouch Pharmacists can now substitute Ryzodeg 70/30 Penfill cartridges instead of Ryzodeg 70/30 FlexTouch prefilled pen under certain conditions, …
TGA green lights cefaclor substitution
An unexpected increase in demand for oral liquid preparations of cefaclor have prompted the Therapeutic Goods Administration (TGA) to issue a Serious Scarcity Substitution Instrument (SSSI) for the medication Pharmacists …
Penicillin V shortage prompts SSSI from TGA
Manufacturing issues responsible for Phenoxymethylpenicillin drought, says regulator A Serious Scarcity Substitution Instrument (SSSI) has been made by the Therapeutic Goods Administration (TGA) to help manage the shortage of the …
